ARTICLE | Clinical News
Onconase ranpirnase regulatory update
December 15, 2008 8:00 AM UTC
Alfacell said completing its rolling NDA for Onconase ranpirnase to treat unresectable malignant mesothelioma would be delayed from this month after preparing materials for the submission took more ti...